VALSARTANA + ANLODIPINO (160,0+5,0) MG COM REV CT BL AL AL X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1057307310042 -
GGREM
552920100133607 -
Código de barras
7896181926054
O que a fonte publica
- Detentor do registro
- ACHÉ LABORATÓRIOS FARMACÊUTICOS S.A
- Princípios ativos
- BESILATO DE ANLODIPINO;VALSARTANA
- Embalagem
- (160,0+5,0) MG COM REV CT BL AL AL X 30
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Genérico
- Classe terapêutica
- C9D3 - ANTAGONISTAS DA ANGIOTENSINA II ASSOCIADOS A ANTAGONISTAS DO CÁLCIO
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
- VALSARTANA + ANLODIPINO (160,0+5,0) MG COM REV CT BL AL AL X 30
- VALSARTANA + ANLODIPINO
- BESILATO DE ANLODIPINO
- VALSARTANA
Dados completos da fonte
{
"name": "VALSARTANA + ANLODIPINO (160,0+5,0) MG COM REV CT BL AL AL X 30",
"holder": "ACHÉ LABORATÓRIOS FARMACÊUTICOS S.A",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896181926054"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "552920100133607",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "60.659.463/0029-92",
"priceRegime": "Regulado",
"productName": "VALSARTANA + ANLODIPINO",
"productType": "Genérico",
"hospitalOnly": false,
"presentation": "(160,0+5,0) MG COM REV CT BL AL AL X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "74.57",
"icms-12": "84.74",
"icms-17": "89.84",
"icms-18": "90.94",
"icms-19": "92.06",
"icms-20": "93.21",
"icms-21": "94.39",
"icms-22": "95.60",
"icms-23": "96.84",
"icms-17.5": "90.39",
"icms-19.5": "92.63",
"icms-20.5": "93.80",
"icms-22.5": "96.22",
"icms-12-alc": "83.72",
"icms-17-alc": "88.77",
"icms-18-alc": "89.85",
"icms-19-alc": "90.96",
"icms-20-alc": "92.09",
"icms-21-alc": "93.26",
"icms-22-alc": "94.46",
"icms-23-alc": "95.68",
"withoutTaxes": "73.68",
"icms-17.5-alc": "89.30",
"icms-19.5-alc": "91.52",
"icms-20.5-alc": "92.67",
"icms-22.5-alc": "95.06"
},
"pisCofinsList": "Positiva",
"substanceText": "BESILATO DE ANLODIPINO;VALSARTANA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "102.79",
"icms-12": "116.81",
"icms-17": "123.84",
"icms-18": "125.35",
"icms-19": "126.90",
"icms-20": "128.48",
"icms-21": "130.11",
"icms-22": "131.77",
"icms-23": "133.48",
"icms-17.5": "124.59",
"icms-19.5": "127.68",
"icms-20.5": "129.29",
"icms-22.5": "132.63",
"icms-12-alc": "115.74",
"icms-17-alc": "122.72",
"icms-18-alc": "124.21",
"icms-19-alc": "125.75",
"icms-20-alc": "127.31",
"icms-21-alc": "128.93",
"icms-22-alc": "130.59",
"icms-23-alc": "132.27",
"withoutTaxes": "101.85",
"icms-17.5-alc": "123.45",
"icms-19.5-alc": "126.52",
"icms-20.5-alc": "128.11",
"icms-22.5-alc": "131.41"
},
"invalidBarcodes": [],
"activeSubstances": [
"BESILATO DE ANLODIPINO",
"VALSARTANA"
],
"therapeuticClass": "C9D3 - ANTAGONISTAS DA ANGIOTENSINA II ASSOCIADOS A ANTAGONISTAS DO CÁLCIO",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1057307310042",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "C9D3",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:552920100133607"